InfuSystem Holdings to Attend Craig-Hallum Conference

The latest announcement is out from InfuSystem Holdings ( (INFU) ).

InfuSystem Holdings announced that its President and CEO, Carrie Lachance, and CFO, Barry Steele, will participate in the 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025, in New York City. This participation highlights the company’s ongoing efforts to engage with investors and stakeholders, potentially impacting its market positioning and investor relations positively.

The most recent analyst rating on (INFU) stock is a Hold with a $10.50 price target. To see the full list of analyst forecasts on InfuSystem Holdings stock, see the INFU Stock Forecast page.

Spark’s Take on INFU Stock

According to Spark, TipRanks’ AI Analyst, INFU is a Neutral.

InfuSystem Holdings shows strong financial performance with significant revenue growth and strategic initiatives in Oncology and Wound Care. However, the stock is currently overvalued, and challenges in certain revenue streams pose risks. Technical indicators suggest mixed momentum, with short-term bearish signals but longer-term positive trends.

To see Spark’s full report on INFU stock, click here.

More about InfuSystem Holdings

InfuSystem Holdings, Inc. is a leading national healthcare service provider that facilitates outpatient care for durable medical equipment manufacturers and healthcare providers. The company operates under a two-platform model: Patient Services, which includes Oncology, Pain Management, and Wound Therapy, and Device Solutions, which supports Patient Services through direct payer rentals, pump and consumable sales, and biomedical services and repair. InfuSystem is headquartered in Rochester Hills, Michigan, and has Centers of Excellence in several U.S. states and Ontario, Canada.

Average Trading Volume: 260,622

Technical Sentiment Signal: Buy

Current Market Cap: $201.7M

Find detailed analytics on INFU stock on TipRanks’ Stock Analysis page.